# Rapid Eye Movement (REM)-Predominant Central Sleep Apnea With Alpha-Delta Sleep Pattern: A Case Report

**Authors:** Rafeek Kandy, Lubna Alhourani, Mateen Uzbeck, Said Isse, Ali Wahla, Zaid Zoumot, Adam Bennett, Irfan Shafiq

PMC · DOI: 10.7759/cureus.86702 · Cureus · 2025-06-24

## TL;DR

A 32-year-old man with severe sleep apnea had central apneas mainly during REM sleep and an unusual alpha-delta sleep pattern, which were resolved with CPAP therapy.

## Contribution

This case report documents a rare instance of REM-predominant central sleep apnea and its resolution with CPAP therapy.

## Key findings

- CPAP therapy at 6 cmH₂O reduced the apnea-hypopnea index from 65.5/hr to 1.3/hr.
- Central apneas during REM sleep were completely resolved with CPAP therapy.
- The alpha-delta sleep pattern also resolved despite continued use of tramadol and pregabalin.

## Abstract

Central sleep apnea (CSA) occurring predominantly during rapid eye movement (REM) sleep represents an unusual clinical phenomenon, as CSA typically occurs during non-rapid eye movement (NREM) sleep. We present the case of a 32-year-old male with severe obstructive sleep apnea (OSA), with an apnea-hypopnea index (AHI) of 65.5/hr, who exhibited central apneas mainly during REM sleep (central apnea index: 35.9/hr in REM vs. 5.2/hr in NREM), along with concurrent alpha-delta sleep pattern during slow-wave sleep. The patient was taking tramadol 100 mg and pregabalin 300 mg daily for chronic back pain. Continuous positive airway pressure (CPAP) therapy at 6 cmH₂O effectively managed the OSA and resolved both central apneas and the alpha-delta sleep pattern despite continued medication use. The CPAP therapy reduced the total AHI from 65.5/hr to 1.3/hr, with the central apnea index decreasing from 35.9/hr to 0/hr during REM sleep. This case contributes to the limited literature on REM-predominant CSA and demonstrates the efficacy of standard CPAP therapy in this uncommon presentation, suggesting complex interactions among pharmacological agents, sleep architecture, and respiratory control mechanisms.

## Linked entities

- **Chemicals:** tramadol (PubChem CID 19472), pregabalin (PubChem CID 4715169)
- **Diseases:** central sleep apnea (MONDO:0004731), obstructive sleep apnea (MONDO:0007147)

## Full-text entities

- **Diseases:** CSA (MESH:D020182), chronic back pain (MESH:D059350), OSA (MESH:D020181), apnea (MESH:D001049)
- **Chemicals:** tramadol (MESH:D014147), pregabalin (MESH:D000069583)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12290312/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12290312/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC12290312/full.md

---
Source: https://tomesphere.com/paper/PMC12290312